Compounded semaglutide and tirzepatide are the two most widely used medications in this class, with semaglutide featured prominently in the STEP trials and tirzepatide in the SURMOUNT trials
Topical glutathione appears to be safe with no marked adverse effects reported in clinical trials
While our understanding of intestinal maturation comes largely from mouse studies, differences between mouse and human intestinal development exist
Wepner F, Scheuer R, Schuetz-Wieser B, Machacek P, Pieler-Bruha E, Cross HS, Hahne J, Friedrich M
Fatigue ranks among the most commonly reported side effects during the first 48 weeks of GLP-1 therapy, affecting roughly 2540% of users according to clinical trial data
Contact your GP or diabetes care team if you experience persistent irritability, mood swings, symptoms of depression or anxiety, or any emotional changes that are uncharacteristic for you